Ayr Wellness Inc. (OTCMKTS:AYRWF - Get Free Report)'s stock price shot up 4.8% on Monday . The company traded as high as $2.43 and last traded at $2.42. 148,638 shares changed hands during mid-day trading, a decline of 60% from the average session volume of 367,836 shares. The stock had previously closed at $2.31.
Ayr Wellness Stock Performance
The firm's 50 day moving average is $2.39 and its two-hundred day moving average is $2.28. The company has a debt-to-equity ratio of 0.75, a quick ratio of 0.43 and a current ratio of 0.96.
Ayr Wellness (OTCMKTS:AYRWF - Get Free Report) last posted its earnings results on Wednesday, March 13th. The company reported ($0.36) earnings per share for the quarter, missing the consensus estimate of ($0.26) by ($0.10). Ayr Wellness had a negative return on equity of 14.13% and a negative net margin of 58.68%. The firm had revenue of $114.84 million during the quarter, compared to analyst estimates of $114.95 million. Analysts expect that Ayr Wellness Inc. will post -0.62 EPS for the current fiscal year.
Ayr Wellness Company Profile
(
Get Free Report)
Ayr Wellness Inc operates as a vertically-integrated multi-state cannabis operator that cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. It owns and operates a chain of cannabis retail stores under AYR, Liberty Health Sciences, and The Dispensary brand names.
See Also
Before you consider Ayr Wellness, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ayr Wellness wasn't on the list.
While Ayr Wellness currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.